These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8268149)

  • 1. Direct relationship between elevated free testosterone and insulin resistance in hyperprolactinemic women.
    Kim SY; Sung YA; Ko KS; Cho BY; Lee HK; Koh CS; Min HK
    Korean J Intern Med; 1993 Jan; 8(1):8-14. PubMed ID: 8268149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin sensitivity and hyperprolactinemia.
    Tuzcu A; Bahceci M; Dursun M; Turgut C; Bahceci S
    J Endocrinol Invest; 2003 Apr; 26(4):341-6. PubMed ID: 12841542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of body weight, insulin resistance, leptin and adiponectin levels in premenopausal women with hyperprolactinemia.
    Atmaca A; Bilgici B; Ecemis GC; Tuncel OK
    Endocrine; 2013 Dec; 44(3):756-61. PubMed ID: 23529671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding.
    Schriock ED; Buffington CK; Hubert GD; Kurtz BR; Kitabchi AE; Buster JE; Givens JR
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1329-31. PubMed ID: 2967305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women.
    Yavuz D; Deyneli O; Akpinar I; Yildiz E; Gözü H; Sezgin O; Haklar G; Akalin S
    Eur J Endocrinol; 2003 Sep; 149(3):187-93. PubMed ID: 12943520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity.
    Maccario M; Grottoli S; Razzore P; Procopio M; Oleandri SE; Ciccarelli E; Camanni F; Ghigo E
    Eur J Endocrinol; 1996 Aug; 135(2):205-10. PubMed ID: 8810734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free testosterone level correlated with the metabolic abnormalities dependent on central obesity in women with polycystic ovary syndrome.
    Dong Z; Chen X; Li L; Huang J; Yin Q; Yang D
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):355-60. PubMed ID: 22576257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of glucose and insulin during twenty-four hours in hyperprolactinemic women with pituitary microadenoma.
    Seki K; Nagata I
    Gynecol Obstet Invest; 1991; 31(4):222-5. PubMed ID: 1885092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity.
    Ivandić A; Prpić-Krizevac I; Sucić M; Jurić M
    Metabolism; 1998 Jan; 47(1):13-9. PubMed ID: 9440471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women.
    Glickman SP; Rosenfield RL; Bergenstal RM; Helke J
    J Clin Endocrinol Metab; 1982 Aug; 55(2):251-7. PubMed ID: 6282921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.
    Chen MJ; Yang WS; Yang JH; Chen CL; Ho HN; Yang YS
    Hypertension; 2007 Jun; 49(6):1442-7. PubMed ID: 17389259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and advancing age: what role for dehydroepiandrosterone sulfate?
    Paolisso G; Ammendola S; Rotondi M; Gambardella A; Rizzo MR; Mazziotti G; Tagliamonte MR; Carella C; Varricchio M
    Metabolism; 1997 Nov; 46(11):1281-6. PubMed ID: 9361686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
    Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
    Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of insulin sensitivity in hyperprolactinemic subjects by euglycemic hyperinsulinemic clamp technique.
    Tuzcu A; Yalaki S; Arikan S; Gokalp D; Bahcec M; Tuzcu S
    Pituitary; 2009; 12(4):330-4. PubMed ID: 19408128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women.
    Diamond MP; Grainger DA; Laudano AJ; Starick-Zych K; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Apr; 72(4):883-7. PubMed ID: 1826009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype.
    Lerchbaum E; Schwetz V; Rabe T; Giuliani A; Obermayer-Pietsch B
    PLoS One; 2014; 9(10):e108263. PubMed ID: 25310562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The free testosterone to dehydroepiandrosterone sulphate molar ratio as a marker of visceral fat accumulation in premenopausal obese women.
    De Pergola G; Triggiani V; Giorgino F; Cospite MR; Garruti G; Cignarelli M; Guastamacchia E; Giorgino R
    Int J Obes Relat Metab Disord; 1994 Oct; 18(10):659-64. PubMed ID: 7866460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome.
    Luo X; Cai WY; Ma HL; Cong J; Chang H; Gao JS; Shen WJ; Wang Y; Yang XM; Wu XK
    Front Endocrinol (Lausanne); 2021; 12():683040. PubMed ID: 34248844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia.
    Schlechte J; Walkner L; Kathol M
    J Clin Endocrinol Metab; 1992 Sep; 75(3):698-703. PubMed ID: 1517357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.